Login

Nikolaj Sørensen, CEO, Orexo 00:00:00

Share On Facebook Share On Twitter

Orexo

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Exciting Gold Discoveries in Mali's Dan Doko Project
00:10:00
Global venture capital firm focused on multi stage, sector-focused investments|Jenny Lee,Managing Partner,GGV Capital
00:10:00
Capitalizing on Changes in the Diagnostic Sector: Expanding Opportunities and Integrated Solutions
00:10:00
Managing Transmission Investments and Climate Resilience | Rui Chammas, CEO, CTEEP Companhia de Transmissao de Energia Eletrica Paulista.
00:10:00
Q4 2023 Market Recap & 2024 Outlook | Jason Gunkel - Chief Investment Officer, Financial Planner of Syverson Strege
00:10:00
"Annie Duke on Decision-Making and Strategic Investing | Investment Conference 2024"
00:10:00
Sitowise's Leadership Transition: Reflections on 2021 and Future Outlook | Heikki Haasma, CEO, Sitowise Group Oyj.
00:10:00
A2A's Alumni to Alumni highlights inspiration, insights, and innovation, featuring an NTN24 interview with Pedro David Espinoza, CEO of SmileyGo.
00:10:00
CEO Patrik Emanuelsson on Heba's Vision for Sustainable Real Estate | Patrik Emanuelsson, CEO, Heba Real Estate AB.
00:10:00
FBN, a unit of FOX News Media with bureaus in Chicago, discusses Rumble's view that Twitter caused 'the worst, most egregious' implications.
00:10:00
O Cisco Metals: Advancing Gaspe Copper Project and Strategic Partnerships in Canada
00:10:00
First US-based asset management company focusing on blockchain tech|Dan Morehead,Founder and CEO,Pantera Capital

© 2026 Nehu